Skip to main content
SpringerLink
Log in

Multiple Sclerosis and Uveitis

  • Chapter
Uveitis and Immunological Disorders

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 1046 Accesses

Optic neuritis has a well-recognised association with multiple sclerosis (MS). Forty-five percent of patients with MS have been found to have optic atrophy at post mortem [1]. Although MS predominantly involves the optic nerves [2] and the pathways controlling eye movements [3], there also appears to be an association between MS and uveitis.

Retinal periphlebitis was first reported in association with MS in 1944 [4]. There are numerous case reports/ series in the literature reporting an association between MS and uveitis [5, 6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D'Amico DJ, Foster CS (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthal-mol 114(5):593–599

    CAS  Google Scholar 

  2. McDonald WI, Barnes D (1992) The ocular manifestations of multiple sclerosis. I. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 55:747–752

    Article  PubMed  CAS  Google Scholar 

  3. Barnes D, McDonald WI (1992) The ocular manifestations of multiple sclerosis. II. Abnormalities of eye movements. J Neurol Neurosurg Psychiatry 55:863–868

    Article  PubMed  CAS  Google Scholar 

  4. Rucker CW (1945) Sheathing of the retinal veins in multiple sclerosis. JAMA 127:970–973

    Google Scholar 

  5. Chebel S, Boughammoura A, Hizem Y, Frih-Ayed H (2005) Definite multiple sclerosis and uveitis: a two cases report. Eur J Neurol (12):729–731

    Article  PubMed  CAS  Google Scholar 

  6. Lim JI, Tessler HH, Goodwin JA (1991) Anterior granulo-matous uveitis in patients with multiple sclerosis. Ophthal-mol 98:142–145

    CAS  Google Scholar 

  7. Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12:137–142

    Article  PubMed  Google Scholar 

  8. Biousse V, Trichet C, Bloch-Michel E, Roullet E (1999) Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology (52):179–181

    PubMed  CAS  Google Scholar 

  9. Acar MA, Birch MK, Abbot R, Rosenthal AR (1993) Chronic granulomatous anterior uveitis associated with multiple sclerosis. Graefe's Arch Clin Exp Ophthalmol 231:166–168

    Article  CAS  Google Scholar 

  10. James DG, Friedman AI, Graham E (1976) Uveitis. A series of 368 patients. Trans Ophthalmol Soc UK 96:151–157

    Google Scholar 

  11. Bamford CR, Ganley J P, Sibley WA, Laguna J (1978) Uveitis, perivenous sheathing and multiple sclerosis. Neurology 28:119–124

    PubMed  CAS  Google Scholar 

  12. Breger BC, Leopold IH (1966) The incidence of uveitis in multiple sclerosis. Am J Ophthalmol 62:540–545

    Google Scholar 

  13. Rothova A, Buitenhuis H, Meenken C, et al. (1992) Uveitis and systemic disease. Br J Ophthalmol 76:137–141

    Article  PubMed  CAS  Google Scholar 

  14. Edwards LJ, Constantinescu CS (2004) A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004 10:575–581

    Article  Google Scholar 

  15. Smith JR, Rosenbaum JT (2004) Neurological concomitants of uveitis. Br J Ophthalmol 88:1498–1499

    Article  PubMed  CAS  Google Scholar 

  16. Porter R (1972) Uveitis in association with multiple sclerosis. Br J Ophthalmol 58:478–481

    Article  Google Scholar 

  17. Jordan JF, Walter P, Ayertey HD, Brunner R (2003) Intermediate uveitis in childhood preceding the diagnosis of multiple sclerosis: a 13-Year follow-up. Am J Ophthalmol 135:885–886

    Article  PubMed  Google Scholar 

  18. Hanes G, Staugaitis SM, Meisler DM, Lee MS (2004) Isolated granulomatous uveitis presenting twenty-two Years before multiple sclerosis. J Neuroophthalmol 24:346–347

    PubMed  Google Scholar 

  19. Graham EM, Francis DA, Sanders MD, Rudge P (1989) Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry 52:1360–1363

    Article  PubMed  CAS  Google Scholar 

  20. Archambeau PL, Hollenhorst RW, Rucker CS (1965) Posterior uveitis as a manifestation of multiple sclerosis. Mayo Clin Proc 40:544–551

    PubMed  CAS  Google Scholar 

  21. Schmidt S, Wessels L, Augustin A, Klockgether T (2001) Patients with multiple sclerosis and concomitant uveitis/ periphlebitis retinae are not distinct from those without intraocular inflammation. J Neurol Sci 187:49–53

    Article  PubMed  CAS  Google Scholar 

  22. Heinzlef O, Alamowitch S, Sazdovitch V, Chillet P, Joutel A, Tournier-Lasserve E, Roullet E (2000) Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand 101:36–40

    Article  PubMed  CAS  Google Scholar 

  23. Raja SC, Jabs DA, Dunn J P, et al. (1999) Pars planitis: clinical features class II HLA associations. Ophthalmol 106:594–599

    CAS  Google Scholar 

  24. Malinowski SM, Pulido JS, Folk JC (1993) Long term visual outcome and complications associated with pars planitis. Ophthalmology 100:818–825

    PubMed  CAS  Google Scholar 

  25. Chester GH, Blach RK, Cleary PE (1976) Inflammation in the region of the vitreous base: pars planitis. Trans Oph-thalmol Soc UK 96:151–157

    CAS  Google Scholar 

  26. Vine AK (1992) Severe periphlebitis, peripheral retinal ischaemia, and preretinal neovascularization in patients with multiple sclerosis. Am J Ophthalmol 113:28–32

    PubMed  CAS  Google Scholar 

  27. Bachman CR, Rosenthal AR, Beckingsale AB (1985) Granulomatous uveitis in neurological disease. Br J Ophthalmol 69:192–196

    Article  PubMed  CAS  Google Scholar 

  28. Inoue K, Numaga J, Joko S, Izumi S, Kato S, Kawashima H, Fujino Y (2001) A case of multiple sclerosis with granulo-matous uveitis in Japan—use of the antilipoarabinomannan (LAM)-B test in differential diagnosis. Am J Ophthalmol 131:524–526

    Article  PubMed  CAS  Google Scholar 

  29. Sauders MD (1987) Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis. Eye 1:441–465

    Google Scholar 

  30. Lightman S, McDonald WI, Bird AC, Francis DA, Hoskins A, Batchelor JR, et al. (1987) Retinal venous sheathing in multiple sclerosis. Its significance for the pathogenesis of multiple sclerosis. Brain 110:405–414

    Article  PubMed  Google Scholar 

  31. Towler HA, Lightman S (2000) Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol 28:97–102

    Article  CAS  Google Scholar 

  32. Zierhut M, Foster CS (1992) Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Oph-thalmol 23:41–47

    CAS  Google Scholar 

  33. Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Her-reras JM (2001) Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 9:93–102

    Article  PubMed  CAS  Google Scholar 

  34. Kerrison JB, Flynn T, Green R (1994) Retinal pathological changes in multiple sclerosis. Retina 14:445–451

    Article  PubMed  CAS  Google Scholar 

  35. Arnold AC, Pepose JS, Hepler RS, Foos RY (1984) Retinal periphlebitis and retinitis in multiple sclerosis: I. Pathologic characteristics. Ophthalmol 91:255–262

    CAS  Google Scholar 

  36. Engell T, Hvidberg A, Uhrenholdt A (1984) Multiple sclerosis: periphlebitis retinalis and cerebrospinalis. A correlation between periphlebitis retinalis and abnormal technectium brain scintigraphy. Acta Neurol Scand 69:293–297

    Article  PubMed  CAS  Google Scholar 

  37. Jabs DA, Johns CJ (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102(3):297–301

    PubMed  CAS  Google Scholar 

  38. Shah SM, Howard RS, Sarkies NJ, Graham EM (1988) Tuberculosis presenting as retinal vasculitis. J R Soc Med 81(4):232–233

    PubMed  CAS  Google Scholar 

  39. Mochizuki M, Knwabara T, McAllister C, Nussenblatt RB, Gery I (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathologic mechanisms and his-tologic features. Invest Ophthalmol Vis Sci 26(1):1–9

    PubMed  CAS  Google Scholar 

  40. Dick AD (1999) Immune regulation of uveoretinal inflammation. Dev Ophthalmol 30:187–202

    Article  PubMed  CAS  Google Scholar 

  41. Toussaint D, Perier O, Verstappen A, Bervoets S (1983) Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 3:211–220

    PubMed  CAS  Google Scholar 

  42. Shaw PJ, Smith NM, Ince PG, Bates D (1987) Chronic periphlebitis retinae in multiple sclerosis. A histopatho-logical study. J Neurol Sci 77:147–152

    Article  PubMed  CAS  Google Scholar 

  43. Constantinescu CS, Hilliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM (1998) Pathogenesis of neuroim-munologic diseases. Experimental models. Immunol Res 17:217–227

    Article  PubMed  CAS  Google Scholar 

  44. Fritz RB, Chou JC-H, McFarlin DE (1983) Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 130:1024–1026

    PubMed  CAS  Google Scholar 

  45. Fritz RB, Chou JC-H, McFarlin DE (1983) Induction of experimental allergic encephalomyelitis in PL/J and (SJL/ JxPL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol 130:191–194

    PubMed  CAS  Google Scholar 

  46. Constantinescu CS, Lavi E (2000) Anterior uveitis in murine relapsing experimental autoimmune encephalo-myelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res 20:71–76

    Article  PubMed  CAS  Google Scholar 

  47. Hayreh SS (1981) Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations. Invest Oph-thalmol Vis Sci 21:270–281

    CAS  Google Scholar 

  48. Shikishima K, Lee WR, Behan WM, Foulds WS (1993) Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: an ultrastructural study. Exp Eye Res 56:167–175

    Article  PubMed  CAS  Google Scholar 

  49. Verhagen C, Mor F, Cohen IR (1995) T cell immunity to myelin basic protein induces anterior uveitis in Lewis rats. J Neuroimmunol 53:65–71

    Article  Google Scholar 

  50. von Sallmann L, Myers RE, Lerner EM, Stone SH (1967) Vaso-occlusive retinopathy in experimental allergic encephalomyelitis. Arch Ophthalmol 78:112–120

    Google Scholar 

  51. Hu P, Pollard J, Hunt N, Chan-Ling T (1998) Microvascu-lar and cellular responses in the retina of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol 8:487–498

    Article  PubMed  CAS  Google Scholar 

  52. Behan PO, Kies M W, Lisak RP, Sheremata W, Lamarche JB (1973) Immunologic mechanisms in experimental enceph-alomyelitis in nonhuman primates. Arch Neurol 29:4–9

    PubMed  CAS  Google Scholar 

  53. Adams CWM, Poston RN, Buk SJ, Sidhu YS, Vipond H (1985) Inflammatory vasculitis in multiple sclerosis. J Neu-rol 69:269–283

    CAS  Google Scholar 

  54. Wakefield D, Jennings A, McCluskey PJ (2000) Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clin Exp Ophthalmol 28:103–106

    Article  CAS  Google Scholar 

  55. Wakefield D, McCluskey PJ, Penny R (1986) Intravenous pulse methylprednisolone in severe inflammatory eye disease. Arch Ophthalmol 104:847–851

    PubMed  CAS  Google Scholar 

  56. McCluskey PJ, Wakefield D (1987) Intravenous pulse meth-ylprednisolone in scleritis. Arch Ophthalmol 105:793–797

    PubMed  CAS  Google Scholar 

  57. Kadayifcilar S, Gedik S, Eldem B, Balaban H, Kansu T (2004) Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis. Ocul Immunol Inflamm 12:153–157

    Article  PubMed  Google Scholar 

  58. Nussenblatt RB, Palestine AG, Chan C-C, Breen L, Caruso R (1984) Improvement of uveitis and optic nerve disease by cyclosporine in a patient with multiple sclerosis. Am J Ophthalmol 97:790–791

    PubMed  CAS  Google Scholar 

  59. Lubin F (2005) History of modern multiple sclerosis therapy. J Neurol 252(Suppl 3):III3–III9

    Article  CAS  Google Scholar 

  60. Panitch H, Goodin D, Francis G, et al. (2005) Benefits of high-dose, high-frequency interferon beta 1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial. J Neurol Sci 239:67–74

    Article  PubMed  CAS  Google Scholar 

  61. Galetta SL (2001) The controlled high risk avonex multiple sclerosis trial (CHAMPS study). J Neuroophthalmol 21:292–295

    PubMed  CAS  Google Scholar 

  62. CHAMPS Study Group (2001) Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol 132:463–471

    Article  Google Scholar 

  63. Mackensen F, Max R, Becker MD (2006) Interferon therapy for ocular disease. Curr Opin Ophthalmol 17:567–573

    Article  PubMed  Google Scholar 

  64. Becker MD, Heligenhaus A, Hudde T, Storch-Hagenlo-cher B, Wildemann B, Barisani-Asenbauer T, Thimm C, Stubiger N, Fiehn C (2005) Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol 89:1254–1257

    Article  PubMed  CAS  Google Scholar 

  65. Mohan N, Edwards ET, Cupps TR, et al. (2001) Demyeli-nation occurring during anti-tumour necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Retinal Screening Service, David Anderson Building, Foresterhill Road, Aberdeen, AB25 2ZP, UK

    Graeme J. Williams

Authors
  1. Graeme J. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Williams, G. (2009). Multiple Sclerosis and Uveitis. In: Uveitis and Immunological Disorders. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69459-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69459-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69458-8

  • Online ISBN: 978-3-540-69459-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation